CryptoTax was founded in 2017 as Australia's first dedicated accounting and taxation advisory firm for the cryptocurrency community.

Our dedicated team is led by Partner-in-Charge, Andrew Bragg, operating from RJSanderson at Suite 1/128 Jolimont Rd, East Melbourne VIC 3002 as well as the Mornington Peninsula office. Andrew is recognised as a technically astute and perceptive practitioner, who delivers tailored, practical outcomes to his clients. He works closely with his clients to quickly gain a thorough understanding of their complete tax position, and provides solutions that are technically sound, practical and commercial. He is a regular expert commentator and presenter on cryptocurrency tax issues, and a member of the commentary panel at the Blockchain Centre.

The team at Cryptotax take tremendous pride in giving back to the community where possible.

Cryptotax in association with RJSanderson have teamed up to support a very important charity close to our hearts; Rare Cancers Australia (RCA). We are proud to be able to provide quality initial tax consultations to our new Cryptotax clients in return for a $50 or more donation to the amazing people over at RCA as our firm’s way to give back in a more formalised manner. Our firm is passionate in supporting this fantastic charity through the provision of initial pro bono accounting advice services together with other support via monetary donations.

A little bit about Rare Cancers Australia Ltd (RCA)

Rare Cancers Australia Ltd (RCA) is a charity whose purpose is to improve the lives and health outcomes of Australians living with rare and less common cancers. As distinct from common cancers (breast, prostate, bowel, lung and melanoma) there is very little patient support offered to RLC cancer patients. RCA works tirelessly to ensure that this cancer group will never be forgotten or ignored again.

A primary goal of RCA is to ensure the Federal and State governments understand the need for urgent reform and action around equity of access to clinical trials, approval and funding of therapies, radio-oncology, early diagnosis, genetic profiling and detection of rare cancers. Rare Cancers Australia (RCA) takes a proactive stance to ensure Australians will have access to the cutting-edge best in class treatments and technologies that target rare cancers when they need them.

The aim is to increase survivorship for patients with rare and less common cancers and highlight the opportunities for change that will ensure this becomes a reality.

Our Industry